神経血栓除去装置市場：製品、治療用途、最終用途別-2025～2030年の世界予測

神経血栓除去装置市場は、2023年に7億8,001万米ドルと評価され、2024年には8億7,500万米ドルに達すると予測され、CAGR 12.66%で成長し、2030年には17億9,713万米ドルに達すると予測されています。

神経血栓除去装置は、急性虚血性脳卒中の治療に不可欠であり、脳動脈から血栓を物理的に除去するために使用されます。高齢化や糖尿病・高血圧などの生活習慣病の増加に伴い、脳卒中発症率が世界的に上昇していることから、その必要性が強調されています。その用途は病院や神経科専門クリニックなどの医療施設に及び、エンドユーザーは神経学やインターベンショナル・ラジオロジーを専門とする医療従事者です。市場の成長は主に、精度と安全性を高めた次世代リトリーバーや吸引装置の開発など、技術の進歩によってもたらされます。最近では、脳卒中管理に対する政府支援の増加と有利な償還ポリシーが有利な機会をもたらしています。しかし、特に新興国市場では、機器や手技のコストが高いことに加え、それらを操作する熟練した専門家が不足していることが、市場抑制要因となっています。費用対効果の高いソリューションを開拓し、アジアやアフリカの未開拓市場への参入を拡大することに機会があります。このセグメントのイノベーションは、操作性を向上させる機器の小型化や、迅速かつ正確な血栓除去をサポートするAIを搭載した診断・手術ツールの開発に焦点を当てることができます。市場関係者はまた、臨床医向けの研修プログラムを強化するために、政府機関や医療機関との協力も検討すべきです。とはいえ、薬理学的血栓溶解療法のような代替療法との競合に加え、厳しい規制ポリシーが継続的な課題となっています。このような課題にもかかわらず、神経血栓摘出術市場は、継続的な研究開発投資と戦略的パートナーシップに後押しされ、大幅な成長が見込まれています。イノベーターは、デバイスの有効性と患者の転帰を改善することに注力すべきであり、ナノ技術とバイオセンサーの統合を模索する可能性もあります。全体として、市場はダイナミックであり、脳卒中治療と介入策の改善に対する需要の高まりに対応するための技術革新と戦略的拡大の余地が大きいです。

市場力学：急速に進化する神経血栓除去装置市場の主要市場洞察を公開

神経血栓除去装置市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネス機会の獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 急性虚血性脳卒中の世界の増加
  • 脳卒中予防のための世界各国政府による取り組み
  • 神経血栓除去術に対する人々の意識の高まり
• 市場抑制要因
  • 厳しく複雑な規制の枠組み
• 市場機会
  • 先進的な神経血栓除去装置の開発拡大
  • 市場参入企業による投資の増加と償還ポリシーの利用可能性
• 市場課題
  • 神経血栓除去装置に関連するリスク

ポーターのファイブフォース：神経血栓除去装置市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、神経血栓除去装置市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォースフレームワークは、企業の競合を評価し、戦略的機会を探るための明確な手法を記載しています。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これら洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：神経血栓除去装置市場における外部からの影響の把握

外部マクロ環境要因は、神経血栓除去装置市場の業績力学を形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を記載しています。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析：神経血栓除去装置市場における競合情勢の把握

神経血栓除去装置市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、セグメント化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニングマトリックス：神経血栓除去装置市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、神経血栓除去装置市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨：神経血栓除去装置市場における成功への道筋を描く

神経血栓除去装置市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネス機会を活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目セグメントを網羅した市場の包括的な分析を提供しています。

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力を評価します。

2.市場の開拓度：新興市場における成長機会を特定し、既存セグメントにおける拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを記載しています。

3.市場の多様化：最近の製品発売、未開拓の地域、産業の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発とイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています。

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、地域はどこか？

3.市場を形成する主要技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 世界中で急性虚血性脳卒中の発症率が上昇
    • 脳卒中予防のための世界各国の政府による取り組み
    • 国民の間で神経血栓除去術に対する認識が高まる
  • 抑制要因
    • 厳格で複雑な規制枠組み
  • 機会
    • 先進的神経血栓除去装置の開発の拡大
    • 市場参入企業による投資の増加と償還ポリシーの利用可能性
  • 課題
    • 神経血栓除去装置に関連するリスク
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治
  • 経済
  • 社会
  • 技術
  • 法律
  • 環境

第6章 神経血栓除去装置市場：製品別

• イントロダクション
• 吸引装置
• クロットレトリーバー
• 血管スネア

第7章 神経血栓除去装置市場：治療用途別

• イントロダクション
• 動静脈奇形（AVM）とAV瘻孔
• 脳動脈瘤
• 脳動脈狭窄症
• 虚血性脳卒中

第8章 神経血栓除去装置市場：最終用途別

• イントロダクション
• 外来手術センター
• 救急クリニック
• 病院

第9章 南北アメリカの神経血栓除去装置市場

• イントロダクション
• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋の神経血栓除去装置市場

• イントロダクション
• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの神経血栓除去装置市場

• イントロダクション
• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析、2023年
• FPNVポジショニングマトリックス、2023年
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Abbott Laboratories
• Acandis GmbH
• Argon Medical Devices, Inc.
• Boston Scientific Corporation
• Edwards Lifesciences Corporation
• Johnson & Johnson Services, Inc.
• Koninklijke Philips N.V.
• Medtronic Plc
• NeuroVasc Technologies, Inc.
• Penumbra, Inc.
• Stryker Corporation
• Teleflex Incorporated
• Terumo Corporation
• Vesalio, LLC

LIST OF FIGURES

• FIGURE 1. NEUROTHROMBECTOMY DEVICES MARKET RESEARCH PROCESS
• FIGURE 2. NEUROTHROMBECTOMY DEVICES MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. NEUROTHROMBECTOMY DEVICES MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. NEUROTHROMBECTOMY DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. NEUROTHROMBECTOMY DEVICES MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. NEUROTHROMBECTOMY DEVICES MARKET DYNAMICS
• TABLE 7. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION/SUCTION DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY CLOT RETRIEVERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY VASCULAR SNARES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ARTERIOVENOUS MALFORMATIONS (AVMS) & AV FISTULAS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY CEREBRAL ANEURYSMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY CEREBRAL ARTERY STENOSIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ISCHEMIC STROKE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY EMERGENCY CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 24. ARGENTINA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 25. ARGENTINA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 26. ARGENTINA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 27. BRAZIL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 28. BRAZIL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 29. BRAZIL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 30. CANADA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 31. CANADA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 32. CANADA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 33. MEXICO NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 34. MEXICO NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 35. MEXICO NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 36. UNITED STATES NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 37. UNITED STATES NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 38. UNITED STATES NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 39. UNITED STATES NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 40. ASIA-PACIFIC NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 41. ASIA-PACIFIC NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 42. ASIA-PACIFIC NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 43. ASIA-PACIFIC NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 44. AUSTRALIA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 45. AUSTRALIA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 46. AUSTRALIA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 47. CHINA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 48. CHINA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 49. CHINA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 50. INDIA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 51. INDIA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 52. INDIA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 53. INDONESIA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 54. INDONESIA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 55. INDONESIA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 56. JAPAN NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 57. JAPAN NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 58. JAPAN NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 59. MALAYSIA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 60. MALAYSIA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 61. MALAYSIA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 62. PHILIPPINES NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 63. PHILIPPINES NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 64. PHILIPPINES NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 65. SINGAPORE NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 66. SINGAPORE NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 67. SINGAPORE NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 68. SOUTH KOREA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 69. SOUTH KOREA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 70. SOUTH KOREA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 71. TAIWAN NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 72. TAIWAN NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 73. TAIWAN NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 74. THAILAND NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 75. THAILAND NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 76. THAILAND NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 77. VIETNAM NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 78. VIETNAM NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 79. VIETNAM NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 80. EUROPE, MIDDLE EAST & AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 81. EUROPE, MIDDLE EAST & AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 82. EUROPE, MIDDLE EAST & AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 83. EUROPE, MIDDLE EAST & AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 84. DENMARK NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 85. DENMARK NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 86. DENMARK NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 87. EGYPT NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 88. EGYPT NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 89. EGYPT NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 90. FINLAND NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 91. FINLAND NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 92. FINLAND NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 93. FRANCE NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 94. FRANCE NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 95. FRANCE NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 96. GERMANY NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 97. GERMANY NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 98. GERMANY NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 99. ISRAEL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 100. ISRAEL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 101. ISRAEL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 102. ITALY NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 103. ITALY NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 104. ITALY NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 105. NETHERLANDS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 106. NETHERLANDS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 107. NETHERLANDS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 108. NIGERIA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 109. NIGERIA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 110. NIGERIA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 111. NORWAY NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 112. NORWAY NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 113. NORWAY NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 114. POLAND NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 115. POLAND NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 116. POLAND NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 117. QATAR NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 118. QATAR NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 119. QATAR NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 120. RUSSIA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 121. RUSSIA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 122. RUSSIA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 123. SAUDI ARABIA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 124. SAUDI ARABIA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 125. SAUDI ARABIA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 126. SOUTH AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 127. SOUTH AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 128. SOUTH AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 129. SPAIN NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 130. SPAIN NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 131. SPAIN NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 132. SWEDEN NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 133. SWEDEN NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 134. SWEDEN NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 135. SWITZERLAND NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 136. SWITZERLAND NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 137. SWITZERLAND NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 138. TURKEY NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 139. TURKEY NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 140. TURKEY NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 141. UNITED ARAB EMIRATES NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 142. UNITED ARAB EMIRATES NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 143. UNITED ARAB EMIRATES NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 144. UNITED KINGDOM NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 145. UNITED KINGDOM NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
• TABLE 146. UNITED KINGDOM NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 147. NEUROTHROMBECTOMY DEVICES MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 148. NEUROTHROMBECTOMY DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

The Neurothrombectomy Devices Market was valued at USD 780.01 million in 2023, expected to reach USD 875.00 million in 2024, and is projected to grow at a CAGR of 12.66%, to USD 1,797.13 million by 2030.

Neurothrombectomy devices are integral in the treatment of acute ischemic strokes, employed to physically remove blood clots from cerebral arteries. The necessity of these devices is underscored by the rising incidence of strokes globally, coupled with an aging population and increasing prevalence of lifestyle diseases like diabetes and hypertension. Their application spans healthcare facilities such as hospitals and specialty neurology clinics, with end-users being healthcare professionals specializing in neurology and interventional radiology. Market growth is primarily driven by advancements in technology, including the development of next-generation retrievers and aspiration devices that offer increased precision and safety. Recently, increasing government support for stroke management, alongside favorable reimbursement policies, presents lucrative opportunities. However, market constraints include the high cost of devices and procedures, coupled with a dearth of skilled professionals to operate them, especially in developing regions. Opportunities lie in developing cost-effective solutions and expanding reach to untapped markets in Asia and Africa. Innovations in the field may focus on miniaturization of devices for enhanced maneuverability and development of AI-powered diagnostic and surgical tools to support swift and precise clot removal. Market players should also consider collaboration with government bodies and health organizations to enhance training programs for clinicians. Nonetheless, stringent regulatory policies pose ongoing challenges, alongside the competition from alternative therapies like pharmacological thrombolysis. Despite these challenges, the neurothrombectomy market is expected to witness substantial growth, fueled by continuous R&D investments and strategic partnerships. Innovators should focus on improving device efficacy and patient outcomes, potentially exploring the integration of nanotechnology and biosensor advancements. Overall, the market is dynamic, with substantial scope for innovation and strategic expansion to cater to the growing demand for improved stroke treatments and interventions.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Neurothrombectomy Devices Market

The Neurothrombectomy Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising incidences of acute ischemic stroke globally
  • Initiatives by government worldwide for the prevention of stroke
  • Growing awareness about the neurothrombectomy among the population
• Market Restraints
  • Stringent and complex regulatory framework
• Market Opportunities
  • Growing development of advanced neurothrombectomy devices
  • Increasing investments by market players and availability of reimbursement policies
• Market Challenges
  • Risks associated with the neurothrombectomy devices

Porter's Five Forces: A Strategic Tool for Navigating the Neurothrombectomy Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Neurothrombectomy Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Neurothrombectomy Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Neurothrombectomy Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Neurothrombectomy Devices Market

A detailed market share analysis in the Neurothrombectomy Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Neurothrombectomy Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Neurothrombectomy Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Neurothrombectomy Devices Market

A strategic analysis of the Neurothrombectomy Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Neurothrombectomy Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Acandis GmbH, Argon Medical Devices, Inc., Boston Scientific Corporation, Edwards Lifesciences Corporation, Johnson & Johnson Services, Inc., Koninklijke Philips N.V., Medtronic Plc, NeuroVasc Technologies, Inc., Penumbra, Inc., Stryker Corporation, Teleflex Incorporated, Terumo Corporation, and Vesalio, LLC.

Market Segmentation & Coverage

This research report categorizes the Neurothrombectomy Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Aspiration/Suction Devices, Clot Retrievers, and Vascular Snares.
• Based on Therapeutic Application, market is studied across Arteriovenous Malformations (AVMs) & AV Fistulas, Cerebral Aneurysms, Cerebral Artery Stenosis, and Ischemic Stroke.
• Based on End-Use, market is studied across Ambulatory Surgical Centers, Emergency Clinics, and Hospitals.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising incidences of acute ischemic stroke globally
    • 5.1.1.2. Initiatives by government worldwide for the prevention of stroke
    • 5.1.1.3. Growing awareness about the neurothrombectomy among the population
  • 5.1.2. Restraints
    • 5.1.2.1. Stringent and complex regulatory framework
  • 5.1.3. Opportunities
    • 5.1.3.1. Growing development of advanced neurothrombectomy devices
    • 5.1.3.2. Increasing investments by market players and availability of reimbursement policies
  • 5.1.4. Challenges
    • 5.1.4.1. Risks associated with the neurothrombectomy devices
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Neurothrombectomy Devices Market, by Product

• 6.1. Introduction
• 6.2. Aspiration/Suction Devices
• 6.3. Clot Retrievers
• 6.4. Vascular Snares

7. Neurothrombectomy Devices Market, by Therapeutic Application

• 7.1. Introduction
• 7.2. Arteriovenous Malformations (AVMs) & AV Fistulas
• 7.3. Cerebral Aneurysms
• 7.4. Cerebral Artery Stenosis
• 7.5. Ischemic Stroke

8. Neurothrombectomy Devices Market, by End-Use

• 8.1. Introduction
• 8.2. Ambulatory Surgical Centers
• 8.3. Emergency Clinics
• 8.4. Hospitals

9. Americas Neurothrombectomy Devices Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Neurothrombectomy Devices Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Neurothrombectomy Devices Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. Acandis GmbH
• 3. Argon Medical Devices, Inc.
• 4. Boston Scientific Corporation
• 5. Edwards Lifesciences Corporation
• 6. Johnson & Johnson Services, Inc.
• 7. Koninklijke Philips N.V.
• 8. Medtronic Plc
• 9. NeuroVasc Technologies, Inc.
• 10. Penumbra, Inc.
• 11. Stryker Corporation
• 12. Teleflex Incorporated
• 13. Terumo Corporation
• 14. Vesalio, LLC